257
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Cetirizine, Doxepine, and Hydroxyzine in the Treatment of Pruritus due to Sulfur Mustard: A Randomized Clinical Trial

, , , &
Pages 249-255 | Published online: 10 Oct 2008

REFERENCES

  • Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997; 19: 29–35.
  • Weldon DR. Quality of life in patients with urticaria. Allergy Asthma Proc 2006; 27: 96–99.
  • Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006; 154: 719–725.
  • Duque MI, Yosipovitch G, Chan YH, Smith R, Levy P. Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. J Am Acad Dermatol 2005; 53: 504–508.
  • Schmack I, Kruse FE, Bauer A, Volcker HE, Dithmar S. Neurodermatitis. A risk factor for the development of squamous cell carcinoma. Ophthalmologe 2006; 103: 141–143.
  • Weisshaar E, Dunker N, Domrose U, Neumann KH, Gollnick H. Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy. Clin Nephrol 2003; 59: 124–129.
  • Bernhard JD. Itch: Mechanism and Management of Pruritus; New York: McGraw-Hill Company, 1994.
  • Arnold AJ, Simpson JG, Jones HE, Ahmed AR. Suppression of histamine-induced pruritus by hydroxyzine and various neuroleptics. J Am Acad Dermatol 1979; 1: 509–512.
  • Le HQ, Knudsen SJ. Exposure to a First World War blistering agent. Emerg Med J 2006; 23: 296–299.
  • Steven L. Jinks, Carstens E. Responses of superficial dorsal horn neurons to intradermal serotonin and other irritants: Comparison with scratching behavior. J Neurophysiol 2002; 87: 1280–1289.
  • Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005; 214: 198–209.
  • Pechura M, Rall DP. Dermatological Effects of mustard and agents and lewisite. In: Veterans at Risk: The Health Effects of Mustard Gas and Lewisite. Washington, D.C.: The National Academy of Sciences; 1993:148–158.
  • Willems, JL. Clinical management of mustard gas casualties. Ann Med Mil Belg 1989; 3: S1–S61.
  • Khateri S, Ghanei M, Soroush M, Haines D. Incidence of lung, eye and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occ Environ Med 2003; 452: 1136–1143.
  • Bullman T, Kang H. A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gGas. Ann Epidemiol 2000; 10: 333–338.
  • Balali-Mood M, Hefazi M, Mahmoudi M, et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005; 19: 713–721.
  • Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992; 128: 775–780.
  • Dabrowska MI, Becks LL, Lell JL, et al. Sulfur mustard induces apoptosis and necrosis in endothelial cell. Toxicol Appl Pharmacol 1996; 141: 568–583.
  • Rice P. Sulphur mustard injuries of the skin. Pathophysiology and management. Toxicol Rev 2003; 22: 111–118.
  • Kadar T, Fishbine E, Meshulam J, et al. A topical skin protectant against chemical warfare agents. Isr Med Assoc J 2003; 5: 717–719.
  • Anshoo G, Singh S, Kulkarni AS, Pant SC, Vijayaraghavan R. Protective effect of Aloe vera L. gel against sulphur mustard-induced systemic toxicity and skin lesions. Indian J Pharmacol 2005; 37: 103–110.
  • Balaskas EV, Bamihas GI, Karamouzis M, Voyitasis G, Tourkantonis A. “Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients,” J Nephron 1998; 78:395–402.
  • Breneman D, Bronsky EA, Bruce S, et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995; 33: 192–198.
  • Tharp MD. Cetirizine: a new therapeutic alternative for chronic urticaria. Cutis 1996; 58: 94–98.
  • Greaves MW. Antihistamines in dermatology. Skin Pharmacol Physiol 2005; 18: 220–229.
  • Monroe EW. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther 1992; 14: 17–21.
  • Lambert D, Hantzperg M, Danglas P, Bloom M. Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria. Allerg Immunol (Paris) 1993; 25: 235–240.
  • Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. Br J Dermatol 1988; 119(1): 67–71.
  • Estelle F, Simons R. Advances in H1-antihistamines. NEJM 2004; 351: 2203–2217.
  • Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 1990; 86: 1014–1018.
  • Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 2003; 148: 1212–1221.
  • Klein PA, Clark RAF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 1522–1525.
  • Nordness M, et al. High dose cetirizine: A case report. Cutis 2003; 71:296.
  • Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004; 113: 134–140.
  • Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 1995; 95: 685–693.
  • Diepgen TL. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002; 13: 278–286.
  • Dillman JF 3rd, Hege AI, Phillips CS, et al. Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint. J Pharmacol Exp Ther 2006; 317: 76–87.
  • Simpson R, Lindsay CD. Effect of sulphur mustard on human skin cell lines with differential agent sensitivity. J Appl Toxicol 2005; 25: 115–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.